top of page

Clinical Trials meeting series: 3rd meeting

man. 13. feb.

|

Zoom

Academic / Investigator-initiated trials: study design and publication

Registration is closed
See other events
Clinical Trials meeting series: 3rd meeting
Clinical Trials meeting series: 3rd meeting

Time & Location

13. feb. 2023, 15:00 – 16:30

Zoom

About the event

CONNECT Clinical Trials Meeting Series: 3rd Meeting addressing “Samarbeidsforskning og industristøttet utprøverinitierte studier – hva må protokollen inneholde for å sikre en god publikasjon?"

Host:  CONNECT Working Group 2

Date: Monday, February 13th, 2023; 15:00h – 16:30h

Venue:  Please register here to receive the ZOOM details. The meeting will be recorded.

Questions can be submitted via the meeting chat. You are also invited to ask questions and contribute to the discussion following the presentations: just raise your hand virtually and the moderator will give you the word.

AGENDA

15:00h – 15:05h Introduksjon, formål, og agenda Moderators: Ravinder Singh, Director Clinical Research, International Oncology Medical Affairs, Eli Lilly & Aslaug Muggerud, Scientific Advisor Oncology, GSK

15:05h – 15:35h Hva bør være på plass i protokoll for å legge grunnlag for en high impact publikasjon, og innovative studiedesign opp mot feasibility? Jo Røislien, Professor i medisinsk statistikk ved Det helsevitenskapelige fakultet, Universitetet i Stavanger.

15:35h – 16:00h Fra ide til publikasjon i Nature. Erfaringer og suksesskriterier med Alice studien som konkret eksempel Jon Amund Kyte, Head, Department of Clinical Cancer Research, Senior consultant in oncology, Research Group Leader, Department of Cancer Immunology, Oslo University Hospital.

16:00h – 16:10h Suksesskriterier fra et statistisk og protokollmessig perspektiv. Erfaringen fra Alice studien Ragnhild Sørum Falk, Head, Research Group Leader, Oslo Center for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital.

16:10h – 16:30h Industriens perspektiv rundt suksesskriterier for utprøverinitierte studier – Paneldebatt Panel with: Terje Ahlquist (Roche), Cathrine Notland (Pfizer), Ali Areffard (BMS) and Tarje Bergdahl (Novartis)

Contact: Jutta Heix, Head of International Affairs Oslo Cancer Cluster / Project Lead CONNECT; jh@oslocancercluster.no

If you missed the previous meetings in this meeting series: please find the summaries, slides and recordings here:

Kicking off the Clinical Trials meeting series (connectnorway.org)

CONNECT seminar: investigator-initiated clinical trials (connectnorway.org)

Share this event

bottom of page